SIGMAR1 and Parkinson disease: The anxiolytic afobazole, which agonistically affects Sigma1R [269] exhibited neuroprotective properties in the 6-OHDA model of PD in mice, restoring motor activity of experimental animals [270,271], DA levels in the striatum [270,271,272] and increasing the number of TH+ neurons in the SNc [270].